The role of delamanid in the treatment of drug-resistant tuberculosis
Joseph M Lewis,1 Derek J Sloan2,3 1Tropical and Infectious Disease Unit, Royal Liverpool University Hospital, Liverpool, UK; 2Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK; 3Liverpool Heart and Chest Hospital, Liverpool, UK Abstract: Tuberculosis (TB) remains a significant cau...
Saved in:
Main Authors: | Lewis JM (Author), Sloan DJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of delamanid for the treatment of multidrug-resistant tuberculosis
by: Szumowski JD, et al.
Published: (2015) -
Evaluation of the effectiveness of bedaquiline and delamanid treatment among children and adolescents with multi-drug-resistant pulmonary tuberculosis
by: M.I. Sakhelashvili, et al.
Published: (2023) -
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective.
by: Carly A Rodriguez, et al.
Published: (2023) -
Whole Genome Sequencing for the Analysis of Drug Resistant Strains of <i>Mycobacterium tuberculosis</i>: A Systematic Review for Bedaquiline and Delamanid
by: Luisa Maria Nieto Ramirez, et al.
Published: (2020) -
Solid Lipid Nanoparticles Enhancing the Leishmanicidal Activity of Delamanid
by: Javier Santamaría-Aguirre, et al.
Published: (2023)